S
San San Ou
Researcher at Fred Hutchinson Cancer Research Center
Publications - 14
Citations - 846
San San Ou is an academic researcher from Fred Hutchinson Cancer Research Center. The author has contributed to research in topics: HPTN 052 & Viral load. The author has an hindex of 10, co-authored 14 publications receiving 761 citations. Previous affiliations of San San Ou include University of Washington.
Papers
More filters
Journal ArticleDOI
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial
Beatriz Grinsztejn,Mina C. Hosseinipour,Heather J. Ribaudo,Susan Swindells,Joseph J. Eron,Ying Q. Chen,Lei Wang,San San Ou,Maija Anderson,Marybeth McCauley,Theresa Gamble,N. Kumarasamy,James Hakim,Johnstone Kumwenda,José Henrique Pilotto,Sheela Godbole,Suwat Chariyalertsak,Marineide Gonçalves de Melo,Kenneth H. Mayer,Susan H. Eshleman,Estelle Piwowar-Manning,Joseph Makhema,Lisa A. Mills,Ravindre Panchia,Ian Sanne,Joel E. Gallant,Irving F. Hoffman,Taha E. Taha,Karin Nielsen-Saines,David D. Celentano,Max Essex,Diane V. Havlir,Myron S. Cohen +32 more
TL;DR: The clinical benefits recorded, combined with the striking reduction in HIV-1 transmission risk previously reported, provides strong support for earlier initiation of antiretroviral treatment.
Journal ArticleDOI
Undisclosed Antiretroviral Drug Use in a Multinational Clinical Trial (HIV Prevention Trials Network 052)
Jessica M. Fogel,Lei Wang,Teresa L. Parsons,San San Ou,Estelle Piwowar-Manning,Ying Q. Chen,Victor Mudhune,Mina C. Hosseinipour,Johnstone Kumwenda,James Hakim,Suwat Chariyalertsak,Ravindre Panchia,Ian Sanne,Nagalingeswaran Kumarasamy,Beatriz Grinsztejn,Joseph Makhema,José Henrique Pilotto,Breno Santos,Kenneth H. Mayer,Marybeth McCauley,Theresa Gamble,Namandjé N. Bumpus,Craig W. Hendrix,Myron S. Cohen,Susan H. Eshleman +24 more
TL;DR: ARS drugs were detected in follow-up samples from participants who were not receiving study-administered treatment and may be useful in addition to self-report of ARV drug use in some clinical trial settings.
Journal ArticleDOI
Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 Trial.
Susan H. Eshleman,Sarah E. Hudelson,Andrew D. Redd,Ronald Swanstrom,San San Ou,Xinyi Cindy Zhang,Li Hua Ping,Estelle Piwowar-Manning,Stephen F. Porcella,Matthew Sievers,Craig Martens,Daniel Bruno,Elena Dukhovlinova,Marybeth McCauley,Theresa Gamble,Jessica M. Fogel,Devin Sabin,Thomas C. Quinn,Thomas C. Quinn,Laurence Gunde,Madalitso Maliwichi,Nehemiah Nhando,Victor Akelo,Sikhulile Moyo,Ravindre Panchia,Nagalingeswaran Kumarasamy,Nuntisa Chotirosniramit,Marineide Gonçalves de Melo,José Henrique Pilotto,Beatriz Grinsztejn,Kenneth H. Mayer,Kenneth H. Mayer,Ying Q. Chen,James P. Hughes,Myron S. Cohen +34 more
TL;DR: It was demonstrated that antiretroviral therapy (ART) prevents HIV transmission in serodiscordant couples and was the likely source of the partner's infection.
Journal ArticleDOI
Adherence to Early Antiretroviral Therapy: Results From HPTN 052, a Phase III, Multinational Randomized Trial of ART to Prevent HIV-1 Sexual Transmission in Serodiscordant Couples.
Steven A. Safren,Steven A. Safren,Kenneth H. Mayer,Kenneth H. Mayer,San San Ou,Marybeth McCauley,Beatriz Grinsztejn,Mina C. Hosseinipour,Nagalingeswaran Kumarasamy,Theresa Gamble,Irving F. Hoffman,David D. Celentano,Ying Qing Chen,Myron S. Cohen +13 more
TL;DR: Mental health was the only psychosocial variable associated with adherence, and adherence was high among individuals in stable relationships taking ART for prevention, mental health and adherence covaried.
Journal ArticleDOI
Differences in Substance Use, Psychosocial Characteristics and HIV-Related Sexual Risk Behavior Between Black Men Who Have Sex with Men Only (BMSMO) and Black Men Who Have Sex with Men and Women (BMSMW) in Six US Cities
TL;DR: Structural interventions that address factors that may contribute to exchange sex among these men are also warranted, and substance use is an important factor to be considered when developing risk-reduction interventions for BMSMW.